Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
106,181
-
Share change
-
+77,684
-
Total reported value
-
$689,000
-
Price per share
-
$7.14
-
Number of holders
-
8
-
Value change
-
+$555,135
-
Number of buys
-
7
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q3 2017
As of 30 Sep 2017,
Scinai Immunotherapeutics Ltd. - ADSs (BVXV) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
106,181 shares.
The largest 8 holders included
DEUTSCHE BANK AG\, RENAISSANCE TECHNOLOGIES LLC, SABBY MANAGEMENT, LLC, Vantage Investment Advisors, LLC, Edge Wealth Management LLC, LADENBURG THALMANN FINANCIAL SERVICES INC., WELLS FARGO & COMPANY/MN, and MORGAN STANLEY.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.